ADP |
Advanced digital processing |
ARE |
Antioxidant response element |
ATT |
Antitubercular therapy |
BCA |
Bicinchoninic acid |
CA |
Trans-cinnamaldehyde |
CAT |
Catalase |
CPT |
Camptothecin |
DCFDA |
6-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate |
DILI |
Drug-induced liver injury |
DMEM |
Dulbecco’s minimum essential medium |
DNA |
Deoxyribonucleic acid |
DTT |
Dithiothreitol |
EMB |
Ethambutol |
HEPES |
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid |
IC50 |
Half maximal inhibitory concentration |
I/P |
A combination of isoniazid and pyrazinamide |
INH |
Isoniazid |
MAPK |
Mitogen-activated protein kinase |
MTT |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
NLRP3 |
NOD-like receptor pyrin domain-containing-3 |
Nrf2 |
Nuclear factor (erythroid-derived 2)-like 2 |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
PAGE |
Polyacrylamide gel |
PZA |
Pyrazinamide |
ROS |
Reactive oxygen species |
SDS |
Sodium dodecyl sulfate |
SOD |
Superoxide dismutase |
SU |
Sulphoraphane |
TAMH |
Transforming growth factor-α transgenic mouse hepatocytes |
TBARS |
Thiobarbituric acid reactive substances |
TBHP |
Tert-butyl hydroperoxide |
TCA |
Trichloroacetic acid |
TMRM |
Tetramethylrhodamine-methyl-ester |